AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 335.26 billion. The enterprise value is 392.97 billion.

Market Cap	335.26B
Enterprise Value	392.97B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 81.90.

PE Ratio	81.90
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.73, with an EV/FCF ratio of 22.82.

EV / Earnings	96.00
EV / Sales	7.56
EV / EBITDA	15.73
EV / EBIT	23.22
EV / FCF	22.82

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.22.

Current Ratio	0.66
Quick Ratio	0.43
Debt / Equity	20.22
Debt / EBITDA	2.51
Debt / FCF	3.81
Interest Coverage	6.53

Financial Efficiency

Return on equity (ROE) is 62.29% and return on invested capital (ROIC) is 16.13%.

Return on Equity (ROE)	62.29%
Return on Assets (ROA)	8.49%
Return on Invested Capital (ROIC)	16.13%
Return on Capital Employed (ROCE)	19.01%
Revenue Per Employee	989,327
Profits Per Employee	74,427
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	4.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.62% in the last 52 weeks. The beta is 0.60, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+12.62%
50-Day Moving Average	187.14
200-Day Moving Average	174.58
Relative Strength Index (RSI)	45.40
Average Volume (20 Days)	558

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.14

Income Statement

In the last 12 months, AbbVie had revenue of EUR 54.41 billion and earned 4.09 billion in profits. Earnings per share was 2.31.

Revenue	54.41B
Gross Profit	38.29B
Operating Income	17.71B
Pretax Income	3.59B
Net Income	4.09B
EBITDA	25.81B
EBIT	17.71B
Earnings Per Share (EPS)	2.31

Full Income Statement

Balance Sheet

The company has 5.37 billion in cash and 65.70 billion in debt, giving a net cash position of -60.33 billion.

Cash & Cash Equivalents	5.37B
Total Debt	65.70B
Net Cash	-60.33B
Net Cash Per Share	n/a
Equity (Book Value)	3.25B
Book Value Per Share	1.82
Working Capital	-12.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.16 billion and capital expenditures -940.79 million, giving a free cash flow of 17.22 billion.

Operating Cash Flow	18.16B
Capital Expenditures	-940.79M
Free Cash Flow	17.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.37%, with operating and profit margins of 32.54% and 7.59%.

Gross Margin	70.37%
Operating Margin	32.54%
Pretax Margin	6.60%
Profit Margin	7.59%
EBITDA Margin	47.43%
EBIT Margin	32.54%
FCF Margin	31.65%

Dividends & Yields

This stock pays an annual dividend of 5.88, which amounts to a dividend yield of 3.12%.

Dividend Per Share	5.88
Dividend Yield	3.12%
Dividend Growth (YoY)	7.17%
Years of Dividend Growth	6
Payout Ratio	257.71%
Buyback Yield	-0.06%
Shareholder Yield	3.07%
Earnings Yield	1.22%
FCF Yield	5.14%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	n/a